“Can BioShield Effectively Procure Medical Countermeasures that Safeguard the Nation?”
Wednesday, April 18, 2007
Wednesday, April 18, 2007
1:00 p.m. in 1539 Longworth House Office Building
Subcommittee on Emerging Threats, Cybersecurity
and Science and Technology
Hearing
“Can BioShield Effectively Procure Medical Countermeasures
that Safeguard the Nation?”
WITNESSES
PANEL I
Mr. Jim Panek (did not testify)
President and Chief Executive Officer
VaxGen Inc.
Mr. Richard Hollis
Chief Executive Officer
Hollis-Eden Pharmaceuticals, Inc.
James H. Davis, PhD., J.D.
Senior Vice President and General Counsel
Human Genome Sciences
PANEL II
Jeffrey Runge, M.D.
Assistant Secretary for Health Affairs (Acting) and Chief Medical Officer
Office of Health Affairs
U.S. Department of Homeland Security
Gerry Parker, Ph.D., DVM.
Principal Deputy Assistant Secretary
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services
Anthony Fauci, M.D.
Director
National Institutes of Allergy and Infectious Diseases
National Institutes of Health
U.S. Department of Health and Human Services
Jesse Goodman, MD., MPH.
Director
Center for Biologics Evaluation and Research
Food and Drug Administration
U.S. Department of Health and Human Services
There will be no webcast of this hearing
# # #
FOR MORE INFORMATION:
Please contact Dena Graziano or Todd Levett at (202) 225-9978
RELATED DOCUMENTS:
ONLINE VERSION OF THIS DOCUMENT AVAILABLE: http://homeland.house.gov/hearings/index.asp?id=33
